Z. Liu

机构：Handan College, Sichuan University

发表论文 3 篇 · 总被引 2 次 · h-index 1

代表论文

• Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial (2025 · Nature Communications · 被引 2)
• WITHDRAWN: 1971P The efficacy and safety of firmonertinib as first-line therapy in advanced NSCLC with EGFR mutations and co-mutations: A multicenter retrospective study (2025 · Annals of Oncology)
• An integrated Chinese society of clinical oncology of breast cancer (CSCO BC) database from 45809 Chinese breast cancer patients (2019 · The Breast)